Skip to main content

Neurolymphomatosis

  • Chapter
  • First Online:
Lymphoma and Leukemia of the Nervous System
  • 985 Accesses

Abstract

The term neurolymphomatosis (NL) encompasses nerve infiltration by neurotropic neoplastic cells in the setting of an unknown or a known hematologic malignancy. It is a rare neurologic manifestation of non-Hodgkin lymphoma (NHL) and leukemia with a poorly defined incidence. The typical manifestations of NL are of a neuropathy that may affect peripheral nerves, nerve roots, plexus, or cranial nerves. The most common presentations include painful peripheral neuropathy or radiculopathy, cranial neuropathy, painless polyneuropathy and peripheral mononeuropathy or a mononeuropathy multiplex. Successful therapy is contingent upon the recognition of this unique neurological complication, yet the diagnosis is difficult and often elusive. Of all diagnostic tools, imaging studies are of greatest clinical utility. MRI yields abnormal findings in almost 80% of affected patients and FDG-PETappears to be a highly sensitive diagnostic method facilitating identification of NL. There is no known standard treatment for NL and therefore, optimal management is ill defined. Treatment of NL consists of either chemotherapy alone or combined with radiotherapy. An aggressive multimodality therapy can prevent neurological deterioration and is associated with a prolonged survival in a subset of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grisold W, Jellinger K et al (1990) Human neurolymphomatosis in a patient with chronic lymphatic leukemia. Clin Neuropathol 9(5):224–230

    PubMed  CAS  Google Scholar 

  2. Kuroda Y, Nakata H et al (1989) Human neurolymphomatosis by adult T-cell leukemia. Neurology 39(1):144–146

    PubMed  CAS  Google Scholar 

  3. Baehring JM, Damek D et al (2003) Neurolymphomatosis. Neuro Oncol 5(2):104–115

    PubMed  Google Scholar 

  4. Grisariu S, Avni B et al (2010) Neurolymphomatosis: An international primary CNS lymphoma collaborative group report. Blood 115(24):5005–5011

    Article  PubMed  CAS  Google Scholar 

  5. Bezier M, Reguiai Z et al (2009) Neurolymphomatosis associated with Sezary syndrome. Arch Dermatol 145(3):294–296

    Article  PubMed  Google Scholar 

  6. Odabasi Z, Parrott JH et al (2001) Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J Peripher Nerv Syst 6(4):197–203

    Article  PubMed  CAS  Google Scholar 

  7. Julien S, Radosavljevic M et al (1999) AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis. J Immunol 162(3):1551–1558

    PubMed  CAS  Google Scholar 

  8. Larocca LM, Capello D et al (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92(3):1011–1019

    PubMed  CAS  Google Scholar 

  9. McCann KJ, Ashton-Key M et al (2009) Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood 113(19):4677–4680

    Article  PubMed  CAS  Google Scholar 

  10. Montesinos-Rongen M, Kuppers R et al (1999) Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 155(6):2077–2086

    Article  PubMed  CAS  Google Scholar 

  11. Borit A, Altrocchi PH (1971) Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol 24(1):40–49

    PubMed  CAS  Google Scholar 

  12. Pages M, Marty-Double C et al (2004) Sensory neuropathy as revealing symptom of neurolymphomatosis: report of a case with a 15-year duration. Eur Neurol 52(1):57–58

    Article  PubMed  CAS  Google Scholar 

  13. Tajima Y, Sudo K et al (2007) Malignant lymphoma originating in the cauda equina mimicking the inflammatory polyradiculoneuropathy. Intern Med 46(13):1029–1032

    Article  PubMed  Google Scholar 

  14. Kuntzer T, Lobrinus JA et al (2000) Clinicopathological and molecular biological studies in a patient with neurolymphomatosis. Muscle Nerve 23(10):1604–1609

    Article  PubMed  CAS  Google Scholar 

  15. Pals ST, de Gorter DJ et al (2007) Lymphoma dissemination: the other face of lymphocyte homing. Blood 110(9):3102–3111

    Article  PubMed  CAS  Google Scholar 

  16. Drillenburg P, Pals ST (2000) Cell adhesion receptors in lymphoma dissemination. Blood 95(6):1900–1910

    PubMed  CAS  Google Scholar 

  17. Pals ST, Drillenburg P et al (1997) Adhesion molecules in the dissemination of non-Hodgkin’s lymphomas. Acta Haematol 97(1-2):73–80

    Article  PubMed  CAS  Google Scholar 

  18. Aho R, Ekfors T et al (1993) Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyma. Acta Neuropathol 86(1):71–76

    Article  PubMed  CAS  Google Scholar 

  19. Aho R, Kalimo H et al (1997) Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin. J Neuropathol Exp Neurol 56(5):557–568

    Article  PubMed  CAS  Google Scholar 

  20. Albelda SM (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68(1):4–17

    PubMed  CAS  Google Scholar 

  21. Bashir R, Coakham H et al (1992) Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain. J Neurooncol 12(2):103–110

    Article  PubMed  CAS  Google Scholar 

  22. Kern WF, Spier CM et al (1992) Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 79(9):2432–2437

    PubMed  CAS  Google Scholar 

  23. Matsumura Y, Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340(8827):1053–1058

    Article  PubMed  CAS  Google Scholar 

  24. Osterrieder N, Kamil JP et al (2006) Marek’s disease virus: from miasma to model. Nat Rev Microbiol 4(4):283–294

    Article  PubMed  CAS  Google Scholar 

  25. Okada K, Tanaka Y et al (1997) Phenotype analysis of lymphoid cells in Marek’s disease of CD4(+) or CD8(+) T-cell-deficient chickens: occurrence of double negative T-cell tumour. Avian Pathol 26(3):525–534

    Article  PubMed  CAS  Google Scholar 

  26. Bulsara KR, Kadri PA et al (2005) Malignant lymphoma of the trigeminal region. Case illustration. J Neurooncol 73(3):279–280

    Article  PubMed  Google Scholar 

  27. Czepczynski R, Guzikowska-Ruszkowska I et al (2008) Neurolymphomatosis detected by (18)F-FDG PET/CT scan – a case report. Nucl Med Rev Cent East Eur 11(2):73–75

    PubMed  Google Scholar 

  28. Dakwar E, Teja S et al (2004) Sciatic neurolymphomatosis. Neurology 63(9):1751

    PubMed  Google Scholar 

  29. Iplikcioglu AC, Dinc C et al (2006) Primary lymphoma of the trigeminal nerve. Br J Neurosurg 20(2):103–105

    Article  PubMed  Google Scholar 

  30. Karadag D, Karagulle AT et al (2002) Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MR imaging. Eur J Radiol 44(1):16–18

    Article  PubMed  Google Scholar 

  31. Kitzmann AS, Pulido JS et al (2008) Histologic findings in T-cell lymphoma infiltration of the optic nerve. Ophthalmology 115(5):e1–e6

    Article  PubMed  Google Scholar 

  32. Strobel K, Fischer K et al (2007) Sciatic nerve neurolymphomatosis – extent and therapy response assessment with PET/CT. Clin Nucl Med 32(8):646–648

    Article  PubMed  Google Scholar 

  33. Kinoshita M, Izumoto S et al (2003) Primary malignant lymphoma of the trigeminal region treated with rapid infusion of high-dose MTX and radiation: case report and review of the literature. Surg Neurol 60(4):343–348; discussion 348

    Article  PubMed  Google Scholar 

  34. Diaz-Arrastia R, Younger DS et al (1992) Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology 42(6):1136–1141

    PubMed  CAS  Google Scholar 

  35. Baehring J, Cooper D (2004) Neurolymphomatosis. J Neurooncol 68(3):243–244

    Article  PubMed  Google Scholar 

  36. Dong Q, Wong KK et al (2008) Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging. Clin Nucl Med 33(1):30–31

    Article  PubMed  Google Scholar 

  37. Khong P, Pitham T et al (2008) Isolated neurolymphomatosis of the cauda equina and filum terminale: case report. Spine 33(21):E807–E811

    Article  PubMed  Google Scholar 

  38. Kim JH, Jang JH et al (2006) A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol 80(2):209–210

    Article  PubMed  Google Scholar 

  39. Levin N, Soffer D et al (2008) Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol 90(1):77–83

    Article  PubMed  Google Scholar 

  40. Matano S, Shirasaki H et al (2006) Thickening of multiple cranial nerves in a patient with extranodal peripheral T-cell lymphoma. J Neuroimaging 16(2):167–169

    Article  PubMed  Google Scholar 

  41. Moore KR, Blumenthal DT et al (2001) Neurolymphomatosis of the lumbar plexus: high-resolution MR neurography findings. Neurology 57(4):740–742

    PubMed  CAS  Google Scholar 

  42. Shibata-Hamaguchi A, Samuraki M et al (2007) B-cell neurolymphomatosis confined to the peripheral nervous system. J Neurol Sci 260(1–2):249–252

    Article  PubMed  Google Scholar 

  43. Boes M, Pels H et al (2008) High-grade B-cell NHL of the brachial plexus followed by infiltration of the spinal cord. J Neurol 255(1):135–137

    Article  PubMed  CAS  Google Scholar 

  44. Bokstein F, Goor O et al (2005) Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. J Neurooncol 72(2):163–167

    Article  PubMed  Google Scholar 

  45. Ghobrial IM, Buadi F et al (2004) High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis. Cancer 100(11):2403–2407

    Article  PubMed  CAS  Google Scholar 

  46. Grisold W, Klimpfinger M et al (2007) Peripheral nerve involvement in lymphoma: the meninges as the crucial barrier between meningoradicular spread and neurolymphomatosis. J Peripher Nerv Syst 12(1):58–60

    Article  PubMed  Google Scholar 

  47. Kanter P, Zeidman A et al (2005) PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol 74(1):66–69

    Article  PubMed  Google Scholar 

  48. Koerbel A, Roser F et al (2005) Primary non-Hodgkin lymphoma of the cranial nerves mimicking neurofibromatosis Type 2. Case illustration. J Neurosurg 102(6):1166

    Article  PubMed  Google Scholar 

  49. Kosa SC, Peller PJ et al (2009) T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology 72(1):98

    Article  PubMed  Google Scholar 

  50. Lin M, Kilanowska J et al (2008) Neurolymphomatosis–diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol 26(1):43–45

    Article  PubMed  CAS  Google Scholar 

  51. Ohta H (2002) A case of non-Hodgkin’s lymphoma infiltrating the brachial plexus detected by Ga-67 scintigraphy. Ann Nucl Med 16(4):297–298

    Article  PubMed  Google Scholar 

  52. Ozturk E, Arpaci F et al (2006) Detection of widespread neurolymphomatosis with 18F-FDG PET. Eur J Nucl Med Mol Imaging 33(8):975–976

    Article  PubMed  Google Scholar 

  53. Peruzzi P, Ray-Chaudhuri A et al (2009) Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. J Neurosurg 111(2):247–251

    Article  PubMed  Google Scholar 

  54. Pietrangeli A, Milella M et al (2000) Brachial plexus neuropathy as unusual onset of diffuse neurolymphomatosis. Neurol Sci 21(4):241–245

    Article  PubMed  CAS  Google Scholar 

  55. Rosso SM, de Bruin HG et al (2006) Diagnosis of neurolymphomatosis with FDG PET. Neurology 67(4):722–723

    Article  PubMed  Google Scholar 

  56. Seror P (2001) Brachial plexus neoplastic lesions assessed by conduction study of medial antebrachial cutaneous nerve. Muscle Nerve 24(8):1068–1070

    Article  PubMed  CAS  Google Scholar 

  57. Shima K, Ishida C et al (2008) A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis. Intern Med 47(12):1159–1160

    Article  PubMed  Google Scholar 

  58. Trojan A, Jermann M et al (2002) Fusion PET-CT imaging of neurolymphomatosis. Ann Oncol 13(5):802–805

    Article  PubMed  CAS  Google Scholar 

  59. Yazawa S, Ohi T et al (2007) Brachial plexus neurolymphomatosis: a discrepancy between electrophysiological and radiological findings. Intern Med 46(8):533–534

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tali Siegal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Siegal, T., Grisariu, S., Avni, B., Baehring, J.M. (2012). Neurolymphomatosis. In: Batchelor, T., DeAngelis, L. (eds) Lymphoma and Leukemia of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7668-0_13

Download citation

Publish with us

Policies and ethics